Investigating how tissue stiffness and genetic factors affect age-related macular degeneration
Official title: Role of Matrix Stiffness and Genetic Risk Factors in AMD-Associated Epithelial-to-Mesenchymal Transition
Funded at University of Iowa · NIH-11144509 · Data updated 2026-11-12
This study is looking at how the stiffness of eye tissue and certain genetic factors might contribute to age-related macular degeneration (AMD), with the hope of finding new ways to treat this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project start | September 1, 2024 |
| Project end | March 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $387,278 |
| NIH project number | 5R01EY036467-02 |
| Project ID | NIH-11144509 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for age-related macular degeneration, particularly those with genetic predispositions or lifestyle factors that contribute to the disease.
✕Less likely to help
Patients with advanced stages of age-related macular degeneration or those without any genetic risk factors may not benefit from this research.
What this research studies
This research explores the relationship between tissue stiffness and genetic risk factors in the development of age-related macular degeneration (AMD). It aims to understand how changes in the extracellular matrix (ECM) stiffness can lead to a process called epithelial-to-mesenchymal transition (EMT) in retinal cells. By using laboratory models, the study will examine how these mechanical changes influence the behavior of retinal pigmented epithelial and choroidal endothelial cells, which are crucial in AMD progression. The findings could pave the way for new treatments targeting the underlying mechanisms of AMD.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that slow down or prevent the progression of age-related macular degeneration.
How similar studies have gone: Previous research has shown promising results in understanding the role of ECM stiffness in other tissues, suggesting that this approach may yield valuable insights for AMD as well.
Where this research is happening
-
University of Iowa
Iowa City, United States Active
Researchers
- Principal investigator: Worthington, Kristan Sorenson — University of Iowa
- Study coordinator: Worthington, Kristan Sorenson
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
ALS risk factors in a long-term ALS study
A long-term ALS study is looking at which factors may influence disease risk and progression in people living with ALS.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetic, behavior, and vascular data
Aims to predict Alzheimer’s disease risk in middle-aged South Asians by combining genetic, lifestyle, and vascular information to catch early changes before dementia develops.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetics, behavior, and vascular data
Aimed at people 21 and older, this project looks at how biology, behavior, and blood vessel health together may signal the early risk of Alzheimer’s disease and related dementias in South Asians.
-
Understanding how risk factors affect progression of cirrhosis and response to statins in patients with cirrhosis
This project follows people with cirrhosis to see what factors speed up their liver disease and whether statin medicines help prevent worsening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.